View source for Paolo Fusar-Poli

'''Paolo Fusar-Poli''' he is a Chair/Full Professor of Preventive Psychiatry, Institute of Psychiatry, Psychology and Neuroscience (IoPPN), King's College London (KCL), which he founded as the first such Chair in the UK. He is also an Honorary Consultant Psychiatrist in the Outreach And Support In South-London ([https://www.meandmymind.nhs.uk/ OASIS]) Service at the South London and Maudsley NHS Foundation Trust, one of the oldest and largest preventive community mental health services worldwide. He is also an Associate Professor at the Department of Brain and Behavioral Sciences, University of Pavia, Italy and a Visiting Professor at the Department of Psychiatry and Psychotherapy Ludwig-Maximilian-University Munich, Germany. 

{| class="wikitable" style="float:right ;border:solid 1px #a2a9b1; background-color: #f8f9fa" cellpadding="5"
|+ <span style="font-size:18px;"></span>
|-
| [[File:Paolo_Fusar_Poli.jpg|center|200px|'''Simone Taioli'''|link=https://topitalianscientists.org/tis/54558/Paolo_Fusar-Poli_-_Top_Italian_Scientist_in_Clinical_Sciences]]
|- 
| '''Nationality''' 
|-
| Italian
|-
| '''Born'''
|-
| May 27, 1977, Cremona, Italy
|-
| '''Education'''
|- 
| style="width:200px;" | University of Pavia (Italy)
|-
|  '''Institutions''' 
|-
|  University of Pavia, Italy (2017-ongoing)
|-
|  King’s College London, UK (2012-ongoing)
|-
|}

==Research interests==
His research utilises clinical prediction, neuroscience and evidence-based medicine to develop new detection and prognostication strategies and preventive interventions for mental disorders, with strong translational applications that impact the lives of young people.

==Notable pubblications==
[https://pubmed.ncbi.nlm.nih.gov/?term=fusar-poli+p 639 PubMed articles published] to November 2025: h-index=133; i10-index=468; citations in 2024=9567; total citations=70470 ([https://scholar.google.co.uk/citations?user=UUBkAgEAAAAJ Google scholar])
*	Transdiagnostic risk of mental disorders in offspring of affected parents: a meta-analysis of family high risk and registry studies. World Psychiatry (IF=79) 2023:22(3)433-448.
*	Dynamic ElecTronic hEalth record detection (DETECT) of individuals at risk of first episode of psychosis: a case-control development and validation study. Lancet Digit Health (IF=36) 2020;2(5):e229-e239.
*	What causes psychosis? An umbrella review of risk and protective factors. World Psychiatry (IF=79) 2018;17:49-66.
*	Development and validation of a clinically based risk calculator for the transdiagnostic prediction of psychosis. JAMA Psychiatry (IF=17) 2017;74:493-500.
*	Deconstructing pretest risk enrichment to optimise prediction of psychosis in individuals at clinical high risk. JAMA Psychiatry (IF=17) 2016;73:1260-1267.
*	Thalamic glutamate levels as a predictor of cortical response during executive functioning in subjects at high risk for psychosis. Arch Gen Psychiatry (IF=17) 2011;68(9):881-890.
*	Distinct effects of {delta}9-tetrahydrocannabinol and cannabidiol on neural activation during emotional processing. Arch Gen Psych (IF=17) 2009;66:95-105.

==Awards and honours==
*	2015 – 2025 Clarivate Analytics/Thompson Reuters [https://recognition.webofscience.com/awards/highly-cited/2020/ Highly Cited Researcher], recognizing the top 1% academics by citations for field and year
*	2023 – 2025 ranked as the Expertscape number one expert in psychotic disorders worldwide ([https://expertscape.com/au/psychosis/Fusar-Poli%2C+P top 0.0021% out of 47,398 scientists]) 
*	2024, 2025 Stanford and Elsevier top 2% scientists worldwide, [https://topresearcherslist.com/Home/Search?AuthFull=fusar-poli ranking 1027th] for citations across all academic disciplines worldwide
*	2023 listed as a [https://pmc.ncbi.nlm.nih.gov/articles/PMC10659646/ dominant entity on schizophrenia research]
*	2025 Top Italian Scientist, ranking [https://topitalianscientists.org/tis/54558/Paolo_Fusar-Poli_-_Top_Italian_Scientist_in_Clinical_Sciences 34th across all medical disciplines and 1st in psychiatry] (as an active academic in Italy)
*	His work has led to the development of a new diagnosis for preventing psychosis: DSM-5 Attenuated Psychosis Syndrome (DSM-5R APS), which acknowledges 15 of his publications.